VF
ENZ

Virtu Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Virtu Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,920
Closed -$4K – 2212
2025
Q1 		$4K Sell
11,920
-36,421
-75% -$20.1K ﹤0.01% 1245
2024
Q4 		$35K Buy
+48,341
New +$50.1K ﹤0.01% 1213
2022
Q3 		– Sell
-30,133
Closed -$62K – 2334
2022
Q2 		$62K Buy
+30,133
New +$74.5K 0.01% 1065
2021
Q1 		– Sell
-12,182
Closed -$31K – 2118
2020
Q4 		$31K Buy
+12,182
New +$26.5K ﹤0.01% 1313
2020
Q3 		– Sell
-11,194
Closed -$25K – 1615
2020
Q2 		$25K Buy
+11,194
New +$28.8K ﹤0.01% 1113
2019
Q3 		– Sell
-48,036
Closed -$162K – 1917
2019
Q2 		$162K Buy
+48,036
New +$169K 0.01% 1062
2018
Q4 		– Sell
-13,237
Closed -$55K – 2061
2018
Q3 		$55K Buy
+13,237
New +$60.1K ﹤0.01% 1291
2018
Q2 		– Sell
-10,321
Closed -$57K – 2589
2018
Q1 		$57K Buy
+10,321
New +$72.7K ﹤0.01% 1691
2017
Q4 		– Sell
-20,263
Closed -$212K – 3125
2017
Q3 		$212K Buy
+20,263
New +$225K 0.01% 1791

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Virtu Financial's ENZ Position: Q2 2025 in Review

Virtu Financial sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 11,920 shares — an estimated $4K sold.

Virtu Financial first reported a position in ENZ in Q3 2017 and held it in 9 quarters. The position peaked at $212K in Q3 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Virtu Financial reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Virtu Financial sold 11,920 Enzo Biochem, Inc. shares in Q2 2025, an estimated $4K.
  • Virtu Financial first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's Enzo Biochem, Inc. position peaked at $212K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.